Novel Potent and Selective σ Ligands: Evaluation of Their Agonist and Antagonist Properties

Novel Potent and Selective σ Ligands: Evaluation of Their Agonist and Antagonist Properties (+)-Methyl (1R,2S)-2-{[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]methyl}-1-phenylcyclopropanecarboxylate [(+)-MR200] Derivatives as Potent and Selective Sigma Receptor Ligands: Stereochemistry and Pharmacological Properties (+)-cis-N-Ethyleneamino-N-normetazocine Derivatives. Novel and Selective σ Ligands with Antagonist Properties Novel 4-(4-Aryl)cyclohexyl-1-(2-pyridyl)piperazines as Δ₈−Δ₇Sterol Isomerase (Emopamil Binding Protein) Selective Ligands with Antiproliferative Activity (+)-and (−)-Phenazocine enantiomers: Evaluation of their dual opioid agonist/σ1 antagonist properties and antinociceptive effects Synthesis and Resolution ofcis-(±)-Methyl (1R,2S/1S,2R)-2-[(4-Hydroxy-4-phenylpiperidin-1-yl)methyl]-1-(4-methylphenyl)cyclopropanecarboxylate [(±)-PPCC)]: New σ Receptor Ligands with Neuroprotective Effect Novel Sigma Receptor Ligands:  Synthesis and Biological Profile Antiproliferative activity of phenylbutyrate ester of haloperidol metabolite II [(±)-MRJF4] in prostate cancer cells Synthesis, σ1, σ2-receptors binding affinity and antiproliferative action of new C1-substituted adamantanes New bifunctional antioxidant/σ1 agonist ligands: Preliminary chemico-physical and biological evaluation